Colloid drug delivery

DJ Burgess. Colloids and colloid drug delivery systems. In J Swarbrick, JC Boylan, eds. Encyclopedia of Pharmaceutical Technology, Vol. 3. New York Marcel Dekker, 1992, pp 31-64. 

HJ Krause, A Schwarz, P Rohdewald. Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs. Int J Pharm 27 145-155, 1985. 

JJ Marty, RC Oppenheim, P Speiser. Nanoparticles-a new colloidal drug delivery system. Pharm Acta Helv 53 17-22, 1978. 

RC Oppenheim. Solid colloidal drug delivery systems nanoparticles. Int J Pharm 8 217-234, 1981. 

Colloidal Drug Delivery Systems, edited by Jorg Kreuter... 

Marty and her colleagues (1978) pointed out that colloidal drug delivery systems were well suited for parenteral administration and may have use as sustained release products. Since gelatin is readily available, has low antigenicity, and has been utilized... 

Marty, J., Oppenheim, R., and Speiser, P. (1978). Nanoparticles—a new colloidal drug delivery system. Pharm. Act.. Helv., 53, 17-23. 

Crommelin, D.J.A. and Schreier, H. (1994), Liposomes, In Kreuter, J. (Ed.) Colloidal Drug Delivery Systems. Marcel Dekker, New York, pp. 73-190. 

Multiparticulate Oral Drug Delivery, edited by Isaac Ghebre-Sellassie Colloidal Drug Delivery Systems, edited by Jorg Kreuter Pharmacokinetics Regulatory Industrial Academic Perspectives, Second Edition, edited by Peter G. Welling and Francis L. S. Tse Drug Stability Principles and Practices, Second Edition, Revised and Expanded, Jens T. Carstensen... 

Polymer-based colloidal drug delivery carriers include polymeric micelles, nano- and micro- particles, or coated particles, and hydrogels [886,890,891]. These are being developed for vaccines and anti-cancer drugs, for targeting of specific treatment sites within the body, and as vehicles for ophthalmic and oral delivery. Methods for the creation of multi-layer coatings are reviewed by Sukhorukov [892] (see also Figure 14.4). Numerous examples are cited by Ravi Kumar [893]. 

This is a method to obtain colloidal drug delivery systems from preformed, well-defined macromolecular materials with known physicochemical and biological properties. Biodegradable nanoparticles from PLA, PLG, PLGA, and poly(E-caprolactone) have been prepared by dispersing the polymers (Vauthier et al. 1991 Couvreur et al. 1995). 

Kreuter, J. (1994) Colloidal Drug Delivery Systems. Marcel Dekker, Inc., New York. 

Marchal-Heussler, L., Orallo, F., Vila Jato, J. L., and Alonso, M. J. (1992), Colloidal drug delivery systems for the eye A comparison of the efficacy of three different polymers Polyisobutylcyanoacrylate, polylacticcoglycolic acid, poly-epsilon-caprolactone, SI P Pharma Sci., 2, 98-104. 

Mtiller-Goymann, C. C. (2004), Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration, Eur. J. Pharm. Biopharm., 58(2), 343-356. 

---